Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen
Inhibition of fatty acid amide hydrolase (FAAH) reduces the gastrointestinal damage produced by non-steroidal anti-inflammatory agents such as sulindac and indomethacin in experimental animals, suggesting that a dual-action FAAH-cyclooxygenase (COX) inhibitor could have useful therapeutic properties...
Saved in:
Main Authors: | Alessandro Deplano (Author), Jessica Karlsson (Author), Mona Svensson (Author), Federica Moraca (Author), Bruno Catalanotti (Author), Christopher J. Fowler (Author), Valentina Onnis (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
by: Alessandro Deplano, et al.
Published: (2019) -
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents
by: Alessandro Deplano, et al.
Published: (2021) -
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
by: Naresh Sunduru, et al.
Published: (2017) -
Pharmacophore modeling and virtual screening for the discovery of new fatty acid amide hydrolase inhibitors
by: Dong-sheng Zhao, et al.
Published: (2011) -
Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
by: Julius T. Dongdem, et al.
Published: (2022)